| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 2,878,000 | 2,663,000 | 2,523,000 | 2,372,000 | | Cost of Revenue | 1,748,000 | 1,595,000 | 1,493,000 | 1,394,000 | | | Gross Profit | 1,130,000 | 1,068,000 | 1,030,000 | 978,000 | | | Operating Expenses | | Research Development | 24,000 | 24,000 | 26,000 | 24,000 | | Selling General and Administrative | 364,000 | 335,000 | 314,000 | 300,000 | | Non Recurring |
-
|
-
| 2,000 | (2,000) | | Others | 216,000 | 210,000 | 207,000 | 196,000 | | | | Total Operating Expenses |
-
|
-
| 549,000 | 518,000 | | | | Operating Income or Loss | 526,000 | 499,000 | 481,000 | 460,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17,000 | (17,000) | 3,000 |
-
| | Earnings Before Interest And Taxes | 543,000 | 482,000 | 484,000 | 460,000 | | Interest Expense | 52,000 | 47,000 | 50,000 | 44,000 | | Income Before Tax | 491,000 | 435,000 | 434,000 | 416,000 | | Income Tax Expense | 137,000 | 122,000 | 115,000 | 106,000 | | Minority Interest | (13,000) | (15,000) | (16,000) | (9,000) | | | | Net Income From Continuing Ops | 349,000 | 307,000 | 316,000 | 305,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 349,000 | 307,000 | 316,000 | 305,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $349,000 | $307,000 | $316,000 | $305,000 |
|
1.49% Nasdaq 
0.27%
Income Statement
